08:56 AM EDT, 07/15/2025 (MT Newswires) -- Health care stocks were mixed premarket Tuesday, with The Health Care Select Sector SPDR Fund (XLV) 0.1% lower and the iShares Biotechnology ETF (IBB) up 0.2%.

ProKidney ( PROK ) shares were up more than 9% after the company said the US Food and Drug Administration has confirmed that the estimated glomerular filtration rate slope can be used as an endpoint to support a biologics license application for rilparencel in patients with chronic kidney disease and type 2 diabetes under the accelerated approval pathway.